Aumed, a.s., Komořanská 326/63, 143 14 Praha - Modřany, Česká republika

+420 603 587 701 English

Covid-19 diagnostics using a newly developed test – AUMED test RT-LAMP Assay SARS-CoV-2

AUMED a.s. is involved in the fight against the Covid-19 pandemic. In cooperation with Protean s.r.o. and Institute of Molecular and Translational Medicine, AUMED a.s. launched a modern diagnostics of SARS-CoV-2 virus under the name AUMED test RT-LAMP Assay SARS-CoV-2. It is a diagnostic using the RT – LAMP Assay method. The test uses the so-called LAMP reaction, which is isothermal amplification of nucleic acids. Unlike the polymerase chain reaction (PCR, qPCR), in which the reaction is performed using temperature cycles, isothermal amplification is performed at a constant temperature so there is no require for any expensive equipment. The results are reliably read based on the color change with the naked eye.

The kit is fully validated. The functional evaluation was successfully performed by the Institute of Molecular and Translational Medicine in Olomouc. Comparison of the kit with the reference RT-PCR assay determined the sensitivity of the assay to be 93% and specificity to 99%. The kit passed all tested parameters and was recommended for use. We have fully prepared production capacity, mass production of the set has started. It is a completely Czech product without dependence on foreign suppliers.

Classical tests are time consuming. That is why we are coming to the market with the AUMED test RT-LAMP Assay SARS-CoV-2, which will facilitate the monitoring of infected people even in smaller or mobile laboratories.

You can find more about the benefits of this test here, or visit our new website dedicated to this test www.aumedtest.cz

MORE ARTICLES

AUMED, a.s. Received Support for the Project “Development of an Immunization Product for Protection Against the Causative Agent of Whooping Cough”

08. 04. 2025

AUMED has received support for the project titled “Development of an Immunization Product for Protection Against the Causative Agent of…

AUMED, a.s. has received support for the project “Innovation in the Production of Immunological Preparations”

07. 04. 2025

AUMED has received support for the project “Innovation in the Production of Immunological Preparations,” registration number CZ.01.01.01/02/24_051/0004982. The essence of…

AUMED Pharma a.s., is expanding the Phage Glow range!

21. 03. 2025

Our subsidiary, AUMED Pharma a.s., is expanding the Phage Glow range with two new product lines: ATOPCARE Atopcare is here…

Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.

European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness


Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s